Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%

Follow BIIB

Alert me

Market cap: $34.8B
P/E: 41.0×
Fwd P/E: 31.5×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	9.31%	7.39%	7.70%	4.58%
Piotroski F-Score Full definition →		5	4	4	3
ROA Full definition →		5.59%	4.50%	4.77%	2.76%
ROIC Full definition →		6.71%	5.61%	5.69%	3.11%
Return on Tangible Assets Full definition →		18.44%	14.89%	14.90%	13.08%
Average Days of Receivables Full definition →		49.83	49.54	50.29	68.63
Free Cash Flow per Share Full definition →		15.43	13.78	16.31	17.20
Free Cash Flow Full definition →		2,262.10	2,019.20	2,401.30	2,540.00
Capital Expenditures Full definition →		(191.50)	(185.40)	(189.50)	(338.80)
Other line items
Cash ROIC Full definition →		7.95%	7.12%	8.22%	9.26%
Accounts Receivable Turnover Full definition →		6.92	7.20	5.91	5.71
Accounts Payable Turnover Full definition →		5.96	5.62	6.50	6.42
Inventory Turnover Full definition →		1.07	1.04	1.15	1.12
Average Days of Payables Full definition →		60.50	65.59	53.72	56.53
Days of Inventory on Hand Full definition →		323.58	329.16	292.04	333.72
Tax Rate Full definition →		(0.16)	(0.17)	(0.15)	(0.17)
Research and Development Expense of Revenue Full definition →		17.71%	17.98%	18.95%	20.08%
Selling, General and Administrative Expense of Revenue Full definition →		24.15%	24.61%	24.84%	25.87%
Share Based Compensation of Revenue Full definition →		3.04%	2.94%	2.96%	2.95%
Operating CF/Net income Full definition →		1.53	1.71	1.89	3.45
Depreciation/Fixed assets Full definition →		0.31	0.35	0.38	0.45
Capex/Depreciation Full definition →		(0.20)	(0.17)	(0.16)	(0.25)
Revenue per Share Full definition →		68.66	67.51	67.51	67.89
Operating CF per Share Full definition →		16.74	15.05	17.60	19.49
Capex per Share Full definition →		(1.31)	(1.27)	(1.29)	(2.29)
Capex to Sales Full definition →		0.02	0.02	0.02	0.03

Show all line items

Columns are period end dates

Stockrow Weekly